GENE ONLINE|News &
Opinion
Blog

2022-03-16| Asia-Pacific

Alliance Formed: SV Investment and Orange Grove Bio Jointly Source and Develop Novel Medications in the U.S. and Korea

by GeneOnline
Share To
The partnership of SV Investment and Orange Grove Bio, in short, is to scout the unicorns and source them for developing the new therapeutics. The combination of unique visions from the East and West will definitely surprise the industry with no doubt. 

It's free! Log in now to read

LATEST
Huawei’s Ambition in Digital Healthcare: The Healthcare Corps Led by Data Lake Technology
2025-03-20
NICE Approves First-Ever Daily Pill for Endometriosis Treatment
2025-03-20
Fast-Tracking Biotech Innovation: How ITRI Is Overcoming Bottlenecks and Fueling Taiwan’s Global Startup Boom
2025-03-19
AI’s Promise to Profits: How IBM is Maximizing Business ROI with Accelerated Computing
2025-03-19
Edge Computing: The Next Big Thing in AI and Automation
2025-03-19
Novo Nordisk Rejoins British Pharmaceutical Industry Association After Suspension
2025-03-19
Study Links Cigars, Pipes, and Smokeless Tobacco to Increased Heart Disease Risk
2025-03-19
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top